ArticleFrontiers in immunology2023

Neoadjuvant tislelizumab combined with chemotherapy in locally advanced oral or oropharyngeal squamous cell carcinoma: a real-world retrospective study.

Wen-Jie Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.